fda on semaglutide US approves weight loss drug Wegovy to prevent cardiovascular events FDA Approves RYBELSUS (oral semaglutide)

Study Wang 2023 aging kidney Duration 8 weeks Dose & Route 25 mg/kg IP once daily Outcome (Mouse) Reduced albuminuria

Self-Assembled Nanomaterials for Chronic Skin Wound Healing

This expanded approval is based on results from the pivotal FLOW phase 3b clinical trial, which demonstrated that once-weekly semaglutide led to a statistically significant 24% reduction in the risk of kidney disease progression, kidney failure, and cardiovascular death compared to placebo, when added to standard care

Mike brings more than just a medical perspective to his clients

Conclusion In summary, glutathione is a powerful antioxidant with numerous benefits for skin health, including detoxification and combating oxidative stress

This seems minor until you consider that chronic dry mouth increases dental decay risk, reduces quality of life, and signals inadequate hydration that has implications for seizure threshold